Literature DB >> 23093477

An update on cross-cultural adaptation of US English SMILEY.

L N Moorthy1, E Weiss, M G E Peterson, A L Hassett, T J A Lehman.   

Abstract

We previously developed a health-related quality of life (HRQOL) tool for children with systemic lupus erythematosus (SLE) that is valid in English for the United States, called Simple Measure of Impact of Lupus Erythematosus in Youngsters (SMILEY). In order to determine the effect of SLE on the well-being of children, adolescents and their parents and examine the response to treatment modalities, it is critical to have an HRQOL tool that is applicable for different cultures. After validation in US English, we reported the translation and cultural adaptation process undertaken by our team to make SMILEY available in the following 13 accepted modern language variants: Danish, Dutch, French (France), German (Germany), Hebrew, Italian, Portuguese (Brazil), Slovene, Spanish (USA and Puerto Rico), Spanish (Spain), Spanish (Argentina), Spanish (Mexico) and Turkish. In this report we will describe the translation and adaptation of SMILEY into Afrikaans, Xhosa, Arabic (Saudi Arabia), Arabic (Egypt), Chinese, Czech, English (UK), German (Austria), German (Switzerland), Greek, Hindi, Hungarian, Japanese, Romanian, Serbian and Spanish for Venezuela. We followed the earlier reported procedure in this study consisting of: establishing collaborative relationships with different physicians caring for children with rheumatic diseases; forward and back translation of SMILEY and revisions; and cultural adaptation of SMILEY content.

Entities:  

Mesh:

Year:  2012        PMID: 23093477     DOI: 10.1177/0961203312461965

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  2 in total

1.  Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration.

Authors:  Lakshmi Nandini Moorthy; Elizabeth Roy; Vamsi Kurra; Margaret G E Peterson; Afton L Hassett; Thomas J A Lehman; Christiaan Scott; Dalia El-Ghoneimy; Shereen Saad; Reem El Feky; Sulaiman Al-Mayouf; Pavla Dolezalova; Hana Malcova; Troels Herlin; Susan Nielsen; Nico Wulffraat; Annet van Royen; Stephen D Marks; Alexandre Belot; Jurgen Brunner; Christian Huemer; Ivan Foeldvari; Gerd Horneff; Traudel Saurenman; Silke Schroeder; Polyxeni Pratsidou-Gertsi; Maria Trachana; Yosef Uziel; Amita Aggarwal; Tamas Constantin; Rolando Cimaz; Theresa Giani; Luca Cantarini; Fernanda Falcini; Silvia Magni Manzoni; Angelo Ravelli; Donato Rigante; Fracnceso Zulian; Takako Miyamae; Shumpei Yokota; Juliana Sato; Claudia S Magalhaes; Claudio A Len; Simone Appenzeller; Sheila Oliveira Knupp; Marta Cristine Rodrigues; Flavio Sztajnbok; Rozana Gasparello de Almeida; Adriana Almeida de Jesus; Lucia Maria de Arruda Campos; Clovis Silva; Calin Lazar; Gordana Susic; Tadej Avcin; Ruben Cuttica; Ruben Burgos-Vargas; Enrique Faugier; Jordi Anton; Consuelo Modesto; Liza Vazquez; Lilliana Barillas; Laura Barinstein; Gary Sterba; Irama Maldonado; Seza Ozen; Ozgur Kasapcopur; Erkan Demirkaya; Susa Benseler
Journal:  Pediatr Rheumatol Online J       Date:  2014-11-25       Impact factor: 3.054

2.  'It is good to have a target in mind': qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus.

Authors:  Eve M D Smith; Sarah L Gorst; Eslam Al-Abadi; Daniel P Hawley; Valentina Leone; Clarissa Pilkington; Athimalaipet V Ramanan; Satyapal Rangaraj; Arani Sridhar; Michael W Beresford; Bridget Young
Journal:  Rheumatology (Oxford)       Date:  2021-12-01       Impact factor: 7.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.